Beam Therapeutics BEAM
NASDAQ BEAM
$24.84 -0.09 (-0.36%)
At close: Oct 21, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) EV to FCF (2022)

Updated

Beam Therapeutics' (BEAM) EV to FCF came in at 81.04 for Q3 2022, up 305.8% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) EV to FCF (2022) Analysis & Trends

For the trailing twelve months through Sep 30, 2022, EV to FCF at Beam Therapeutics was 52.61.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Beam Therapeutics 2.60 Bn -2.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 81.04
Jun 30, 2022 19.97
Mar 31, 2022 24.97
API Access

Beam Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=BEAM&period=max&api_key=YOUR_API_KEY